Wellnex Life Limited (AIM:WNX)

London · Delayed Price · Currency is GBP · Price in GBX

5.50

0.00 (0.00%)

Oct 16, 2026, 8:00 AM GMT

Market Cap	2.67M -66.7%
Revenue (ttm)	12.95M +5.1%
Net Income	-2.37M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	5.50
Previous Close	5.50
Day's Range	5.50 - 5.50
52-Week Range	3.00 - 13.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 11, 2026

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2011

Country Australia

Stock Exchange London Stock Exchange AIM

Ticker Symbol WNX

Financial Performance

In fiscal year 2026, Wellnex Life's revenue was 24.84 million, an increase of 5.13% compared to the previous year's 23.63 million. Losses were -4.55 million, -70.85% less than in 2025.

Financial numbers in AUD Financial Statements